Walgreens Boots Alliance Inc   (WBA)
Other Ticker:  
Price: $20.5800 $-0.91 -4.235%
Day's High: $21.38 Week Perf: -4.85 %
Day's Low: $ 20.55 30 Day Perf: -11.48 %
Volume (M): 10,809 52 Wk High: $ 36.58
Volume (M$): $ 222,449 52 Wk Avg: $26.92
Open: $21.24 52 Wk Low: $19.68

 Market Capitalization (Millions $) 17,755
 Shares Outstanding (Millions) 863
 Employees 325,000
 Revenues (TTM) (Millions $) 138,934
 Net Income (TTM) (Millions $) -4,258
 Cash Flow (TTM) (Millions $) -3,684
 Capital Exp. (TTM) (Millions $) 2,610

Walgreens Boots Alliance Inc
Walgreens Boots Alliance Inc. is a global healthcare and retail company that operates in various segments, including Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The company has over 21,000 stores in more than 25 countries, which makes it one of the largest drugstore chains in the world. It is headquartered in Deerfield, Illinois, United States.

Walgreens Boots Alliance was formed through the merger of Walgreens and Alliance Boots in 201 The company's mission is to be a trusted healthcare partner to customers and communities around the world. Its products and services range from retail pharmacy and health and wellness products to digital health solutions and specialized pharmaceutical services.

Retail Pharmacy USA is the largest segment of the company and includes the drugstore chain Walgreens in the United States. This segment offers retail pharmacy, health and wellness products, and retail clinic services. Walgreens Boots Alliance ranks among the most prominent drugstore chains in the United States, with a team of about 215,000 employees working to keep customers healthy.

Retail Pharmacy International operates in over 10 countries, including the United Kingdom, Mexico, and Chile. This segment also comprises some of the leading international retail pharmacy brands, such as Boots and Benavides. Retail Pharmacy International offers retail pharmacy, health and wellness products, and optical services.

The Pharmaceutical Wholesale segment offers distribution and related services to pharmacies and other healthcare providers. Walgreens Boots Alliance offers a wide range of products, including prescription drugs, consumer health products, and surgical products. Under this segment, the company has two main subsidiaries, namely Alliance Healthcare and International Pharmaceutical Wholesale.

Walgreens Boots Alliance is committed to making healthcare more accessible and affordable. It offers digital health solutions to provide customers with easy access to health information, prescription tracking, and other health-related services. The company is also conscious of its role in the communities it operates in and has partnered with various organizations to develop healthcare programs tailored to local needs.

In summary, Walgreens Boots Alliance Inc. is a leading global healthcare and retail company that provides retail pharmacy, health and wellness products, digital health solutions, and pharmaceutical wholesale services to customers worldwide. The company is committed to making healthcare more accessible and affordable, while also fulfilling its role as an integral part of the communities it serves.

   Company Address: 108 Wilmot Road Deerfield 60015 IL
   Company Phone Number: 315-3700   Stock Exchange / Ticker: NASDAQ WBA
   WBA is expected to report next financial results on March 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Petiq Inc

2. Battling Losses: PetIQ Inc Struggles to Achieve Profitability Despite Impressive Revenue Growth

PETQ Reports Increased Loss Per Share for Recent Fiscal Period
EAGLE, Idaho, Feb. 07, 2024 - PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, announced its financial results for the fourth quarter and full year ended December 31, 2023. Despite some unfavorable numbers, the company remains optimistic about its future performance.
For the most recent fiscal period, PETQ reported a loss per share of $-0.60, compared to $-0.24 in the previous year. The Income per Share also fell from $0.02 to -$0.60 sequentially. However, there was a notable increase in revenue, which grew by 19.937% to $220.78 million from $184.08 million in the same quarter of the previous year.

Nu Skin Enterprises Inc

Nu Skin Enterprises Inc. Reports Significant Decline in 2023 Q4 Revenue and Profits, Raising Concerns About Financial Stability

Nu Skin Enterprises Faces Significant Revenue and Profit Declines in Q4 2023
Nu Skin Enterprises Inc. (NYSE: NUS) recently released its fourth quarter and full-year 2023 financial results, which showed a significant decline in revenue and profits. In the fourth quarter of 2023, the company's revenue decreased by a staggering -6.518% to $488.30 million, compared to $498.27 million in the previous quarter. This decline in revenue directly impacted the company's profits, which plummeted by -87.26% to $0.15 per share, down from $1.16 per share in the corresponding quarter one year ago.
The decline in revenue and profits is a cause for concern for Nu Skin Enterprises shareholders. The company's bottom-line also suffered, with a -87.27% decrease in net income from $57.215 million in the corresponding period a year before to $7.282 million in the fourth quarter of 2023. This significant decline in profits raises doubts about the company's ability to maintain its financial stability and sustainability.

Mckesson Corporation

Despite Strong Revenue, McKesson Corporation's Earnings Decline in Q3 2024

McKesson Corporation, a leading healthcare services company, has experienced a significant increase in its stock performance in recent months. Over the past three months, the company's stock has improved by 15.42%. However, during the month of February, the stock dropped by 2.94%. Despite this dip, McKesson Corporation's stock has reached its 52-week high.
One of the factors contributing to the fluctuation in McKesson Corporation's stock price is its financial performance. In the third quarter of the 2024 earnings season, the company experienced a decline in earnings per share (EPS) while revenue increased. EPS plummeted by -42.3% to $4.42 per share, while revenue showed an admirable increase of 14.765% to $80.90 billion compared to the same reporting season the previous year.

Cvs Health Corporation

CVS Health Corporation Sees Decrease in Fourth Quarter 2023 Earnings Amidst Impressive Revenue Growth

CVS Health Corporation, a leading Pharmacy Services and Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average.
During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpaced the top-line performance of most other companies in the Pharmacy Services and Retail Drugstore sector, as they reported an average revenue advance of 11.61% in the fourth quarter of 2023 compared to the previous year.

Cardinal Health Inc

Cardinal Health Inc Surges Ahead with Spectacular Q2 Revenue Surge: A Promising Outlook for the Pharmacy Services and Retail Drugstore Leader

Cardinal Health Inc, a leading healthcare services company, has shown strong growth in its shares and financial results. With a notable increase in earnings per share (EPS), revenue, and net earnings, the company seems poised for continued success. This article aims to analyze the impact of these positive developments on Cardinal Health Inc's future prospects.
1. Share Performance and Momentum:
Cardinal Health Inc shares have experienced a remarkable improvement of 8.36% in the past 30 days. Over the last 12 months, the shares have advanced by an impressive 75.72%. The shares are now only 1.9% away from reaching their 52-week high of $111.4. This upward trend indicates growing investor confidence and suggests a positive market reception for the company.


Walgreens Boots Alliance Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com